- Home
- Pathology Industry
- Neurological Disease Market and Forecasts, May 2013
Industries
- Pathology (348)
- Drug and Medication (85)
- Medical Facility (38)
- General Medicine and Specialty Medicine (35)
- Healthcare (30)
-
- Drug Discovery and Development (24)
- Managed Care (24)
- Energy & Environment (22)
- Biotechnology (20)
- Diagnostics (20)
- Pharmaceutical (18)
- Agrochemical (16)
- Biological Therapy (16)
- Advanced Material (14)
- Genomics (12)
- Pesticide (10)
- Vitamin and Supplement (9)
- Water Distribution and Treatment (9)
- Blood Supply, Tissue Banking and Transplantation (8)
- Fruit and Vegetable (8)
Top countries
Publication dates
All regions
-
- Bangladesh (2)
- Cambodia (1)
- China (25)
- Georgia (2)
- India (62)
- Indonesia (1)
- Iran (1)
- Israel (4)
- Japan (15)
- Kazakhstan (1)
- Lebanon (2)
- Malaysia (4)
- Mongolia (1)
- Nepal (2)
- Pakistan (2)
- Philippines (5)
- Saudi Arabia (2)
- Singapore (5)
- South Korea (5)
- Sri Lanka (3)
- Taiwan (5)
- Thailand (2)
- Turkey (2)
- Uzbekistan (1)
-
- Austria (4)
- Belarus (1)
- Belgium (4)
- Czech Republic (2)
- Denmark (2)
- Estonia (1)
- Finland (3)
- France (10)
- Germany (16)
- Greece (1)
- Ireland (18)
- Italy (8)
- Lithuania (2)
- Luxembourg (5)
- Moldova, Republic Of (1)
- Netherlands (8)
- Norway (2)
- Portugal (1)
- Romania (3)
- Russian Federation (14)
- Serbia and Montenegro (2)
- Slovakia (slovak Republic) (2)
- Spain (5)
- Sweden (4)
- Switzerland (9)
- Ukraine (2)
- United Kingdom (32)
-
- Australia (52)
- Austria (4)
- Belgium (4)
- Canada (60)
- Czech Republic (2)
- Denmark (2)
- Estonia (1)
- Finland (3)
- France (10)
- Germany (16)
- Greece (1)
- Ireland (18)
- Israel (4)
- Italy (8)
- Japan (15)
- Luxembourg (5)
- Mexico (5)
- Netherlands (8)
- New Zealand (5)
- Norway (2)
- Portugal (1)
- South Korea (5)
- Spain (5)
- Sweden (4)
- Switzerland (9)
- Turkey (2)
- United Kingdom (32)
- United States (404)
data types
- All
- Company Data (1 361)
- Industry Data
- Country Data (407)
Neurological Disease Market and Forecasts, May 2013
You might be interested in: alzheimer's disease, multiple sclerosis, stroke, more »
industry reports
Neurological Disease Industry Overview
- Industry report
- November 2012
- 20 pages
... On the x chromosome Symptoms include neurological and motor deficits such as abnormal hand movements, loss of speech, seizures, and autism Symptoms can be divide into four general stages which outline ...
- Industries: Pathology
Neurological Disease Market Statistics in Canada
- Industry report
- May 2011
- 21 pages
... To neurological disease vary, but are not distinct, across developed and developing nations2 Primary and secondary prevention of neurological disorders remains under- developed3 as does quality improvement ...
Cardiovascular Disease Market (cardiovascular disease, neurological disease, eye disease) in Ireland
- Industry report
- February 2012
- 6 pages
... With haemodynamically significant valvular heart disease. Use in patients with asymptomatic or non-life threatening symptomatic arrhythmias. Unless pacing rescue is available, tambocor should not be given to patients ...
Cardiovascular Disease Sector (cardiovascular disease, neurological disease, eye disease) in Ireland
- Industry report
- April 2011
- 6 pages
... With haemodynamically significant valvular heart disease. Use in patients with asymptomatic or non-life threatening symptomatic arrhythmias. Unless pacing rescue is available, tambocor should not be given to patients ...
Neurological Disease in The United States : Innovation and Technology Trends (neurological disease, autoimmune disease)
- Industry report
- January 2011
- 13 pages
- by Non Governmental Organization (NGO)
... Of health national institute of neurological disorders and stroke what ncats/ctsas can do. * Consortium as well as single institution activity Help change the culture of clinical research*. Make referral ...
- Industries: Pathology
- Countries: United States
Cardiovascular Disease Industry Analysis (cardiovascular disease, neurological disease)
- Industry report
- June 2012
- 114 pages
- by Governmental Agency
... For 5 year study data Patients matched on demographics, history of stroke and heart disease. However, the sponsor does not account for multiple cms records that can serve as a match for one ...
- Industries: Pathology
U.S. Neurological Disease Sector Brief
- Industry report
- February 2012
- 14 pages
... Noah king justin love-tice biology period 4 angelman syndrome description Angelman syndrome (as) also known as happy puppet syndrome, is a severe neurological disorder characterized by profound ...
- Industries: Pathology
- Countries: United States
The Irish Cardiovascular Disease Sector Brief (cardiovascular disease, neurological disease, eye disease)
- Industry report
- March 2012
- 6 pages
... With haemodynamically significant valvular heart disease. Use in patients with asymptomatic or non-life threatening symptomatic arrhythmias. Unless pacing rescue is available, tambocor should not be given to patients ...
The Irish Cardiovascular Disease Industry Brief (cardiovascular disease, neurological disease, eye disease)
- Industry report
- March 2012
- 7 pages
... Indicated in patients with long standing atrial fibrillation in whom there has been no attempt to convert to sinus rhythm, and in patients with haemodynamically significant valvular heart disease. Use in patients ...
The Canadian Cardiovascular Disease Market : Industry Statistics (cardiovascular disease, neurological disease, respiratory disease)
- Industry report
- March 2011
- 33 pages
... Neoplasms circulatory nervous system eye and adnexa . . . Acute myocardial infarction pulmonary heart disease congestive heart failure stroke .. . .. . .. . .. . . . . . . . Hbam expenses lhin ...
» Purchase Premium Reports (From $ 99 - $ 11 400)
About 500 reports for Neurological Disease
Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease
- $ 3 500
- Industry report
- May 2013
- by GBI Research
Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease Summary ...
» Read our Company Profiles
1 Companies for Neurological DiseaseAccessEd
AustraliaReportlinker.com © Copyright 2013. All rights reserved.
